Menu
Recruiting NCT07139821

Dietary Iron Requirements

No phase Interventional Iron Absorption

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Stable iron isotope.
Who it may be relevant to
Registry conditions: Iron Absorption. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Dietary Iron Requirements in US Adults

Overview

Dietary Reference Intakes (DRIs) for iron are based on a relatively small number of studies in European populations. This research study will determine iron needs in a representative sample of adults living in the US using the iron isotope dilution technique. Following administration and equilibration of a stable iron isotope, participants will be followed for a 12 week study period. Blood will be collected every 4 weeks and the isotopic composition will be determined. Results will help update dietary iron guidelines making sure they better match the specific needs of the US population.

Interventions

  • Other Stable iron isotope
    Stable iron isotopes will be used to determine iron requirements.

Primary outcome measures

  • Iron isotope composition in blood [Time frame: 12 weeks]

Eligibility criteria

Inclusion criteria

  • Males and premenopausal females age 18-50 y
  • Previously participated in an iron stable isotope study or willing to consume an oral stable iron isotope and undergo a one-year equilibration period
  • Willing to refrain from iron-containing supplements for the duration of the study
  • Willing to refrain from tobacco smoking for the duration of the study
  • Have not donated blood 3 months prior to the start of the study and willing to refrain from donating blood for the duration of the study
  • Willing to have blood stored for future use
  • Able and willing to comply with study requirements and consent to participate

Exclusion criteria

  • Females: pregnant or lactating or plans to become pregnant during the study period
  • Inability to provide informed consent and engage in informed consent procedures
  • Plans to relocate outside the study area

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 2 centers
  • LSU Pennington Biomedical Research Center — Baton Rouge
  • Cornell University — Ithaca

Identifiers

NCT: NCT07139821 · 2025-036-PBRC

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗